JP2016501515A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501515A5 JP2016501515A5 JP2015539804A JP2015539804A JP2016501515A5 JP 2016501515 A5 JP2016501515 A5 JP 2016501515A5 JP 2015539804 A JP2015539804 A JP 2015539804A JP 2015539804 A JP2015539804 A JP 2015539804A JP 2016501515 A5 JP2016501515 A5 JP 2016501515A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- animal
- stem cell
- vector
- expression cassette
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001465754 Metazoa Species 0.000 claims 9
- 210000000130 stem cell Anatomy 0.000 claims 7
- 239000013598 vector Substances 0.000 claims 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical group 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 3
- 230000008685 targeting Effects 0.000 claims 3
- 108010054218 Factor VIII Proteins 0.000 claims 2
- 208000031220 Hemophilia Diseases 0.000 claims 2
- 208000009292 Hemophilia A Diseases 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000001177 retroviral effect Effects 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 102000001690 Factor VIII Human genes 0.000 claims 1
- 208000032843 Hemorrhage Diseases 0.000 claims 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims 1
- 101001078143 Homo sapiens Integrin alpha-IIb Proteins 0.000 claims 1
- 101000782195 Homo sapiens von Willebrand factor Proteins 0.000 claims 1
- 102100025306 Integrin alpha-IIb Human genes 0.000 claims 1
- 108010035030 Platelet Membrane Glycoprotein IIb Proteins 0.000 claims 1
- 230000000740 bleeding effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 229960000301 factor viii Drugs 0.000 claims 1
- 229940034998 human von willebrand factor Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018135886A JP6975105B2 (ja) | 2012-10-24 | 2018-07-19 | 血小板標的化治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261717951P | 2012-10-24 | 2012-10-24 | |
| US61/717,951 | 2012-10-24 | ||
| PCT/US2013/066651 WO2014066663A1 (en) | 2012-10-24 | 2013-10-24 | Platelet targeted treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018135886A Division JP6975105B2 (ja) | 2012-10-24 | 2018-07-19 | 血小板標的化治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016501515A JP2016501515A (ja) | 2016-01-21 |
| JP2016501515A5 true JP2016501515A5 (enExample) | 2016-11-10 |
Family
ID=50545271
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015539804A Pending JP2016501515A (ja) | 2012-10-24 | 2013-10-24 | 血小板標的化治療 |
| JP2018135886A Active JP6975105B2 (ja) | 2012-10-24 | 2018-07-19 | 血小板標的化治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018135886A Active JP6975105B2 (ja) | 2012-10-24 | 2018-07-19 | 血小板標的化治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US9982034B2 (enExample) |
| EP (2) | EP3859004A1 (enExample) |
| JP (2) | JP2016501515A (enExample) |
| KR (1) | KR101819803B1 (enExample) |
| BR (1) | BR112015009229B1 (enExample) |
| CA (1) | CA2888982C (enExample) |
| DK (1) | DK2912186T3 (enExample) |
| ES (1) | ES2854754T3 (enExample) |
| IL (1) | IL238417B (enExample) |
| PL (1) | PL2912186T3 (enExample) |
| WO (1) | WO2014066663A1 (enExample) |
| ZA (1) | ZA201502945B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11319528B2 (en) | 2015-07-13 | 2022-05-03 | University Of Utah Research Foundation | Methods of making red blood cells and platelets in vitro and uses thereof |
| CA3087344A1 (en) | 2018-01-05 | 2019-07-11 | Platelet Biogenesis, Inc. | Compositions and methods for producing megakaryocytes |
| JP2021529770A (ja) | 2018-06-29 | 2021-11-04 | プレートレット バイオジェネシス， インコーポレイテッド | 薬物送達のための組成物およびその使用方法 |
| WO2020072471A1 (en) * | 2018-10-05 | 2020-04-09 | University Of Utah Research Foundation | Methods of making platelets comprising modified receptors and uses thereof |
| US11767511B2 (en) | 2018-11-30 | 2023-09-26 | Cellphire, Inc. | Platelets as delivery agents |
| EP3887404A4 (en) | 2018-11-30 | 2022-11-02 | Cellphire, Inc. | SLIDES LOADED WITH ANTI-CANCER AGENTS |
| WO2020186193A1 (en) * | 2019-03-13 | 2020-09-17 | Cellphire, Inc. | Canine blood platelet preparations |
| CA3138529C (en) | 2019-05-03 | 2025-10-07 | Cellphire, Inc. | MATERIALS AND PROCESSES FOR THE PRODUCTION OF BLOOD PRODUCTS |
| WO2021034719A1 (en) | 2019-08-16 | 2021-02-25 | Cellphire, Inc. | Thrombosomes as an antiplatelet agent reversal agent |
| US12618076B2 (en) | 2019-10-01 | 2026-05-05 | University Of Utah Research Foundation | Methods of engineering platelets for targeting circulating tumor cells |
| CA3170196A1 (en) | 2020-02-04 | 2021-08-12 | Cellphire, Inc. | Anti-fibrinolytic loaded platelets |
| DE102020111571A1 (de) | 2020-03-11 | 2021-09-16 | Immatics US, Inc. | Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren |
| TW202245814A (zh) | 2021-02-17 | 2022-12-01 | 美商賽菲爾公司 | 用於治療抗血小板誘導的凝血病之凍乾血小板衍生物組成物 |
| US12702682B2 (en) | 2021-11-04 | 2026-08-11 | Cellphire, Inc. | Platelet derivative compositions, and methods of making and using such compositions |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2452892A (en) | 1947-05-07 | 1948-11-02 | Robert A Appleton | Igniter for rockets |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
| IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
| DE69313134T2 (de) | 1992-06-25 | 1998-02-26 | Smithkline Beecham Biolog | Adjuvantien enthaltende impfstoffzusammensetzung |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| ATE234129T1 (de) | 1996-06-18 | 2003-03-15 | Alza Corp | Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten |
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| KR100453132B1 (ko) | 1996-12-20 | 2004-10-15 | 앨자 코포레이션 | 경피 약제 플럭스를 향상시키기 위한 장치 및 방법 |
| US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
| GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
| EP1279401B1 (en) | 1997-09-05 | 2008-01-09 | GlaxoSmithKline Biologicals S.A. | Oil in water emulsions containing saponins |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| CN1285753A (zh) | 1997-12-02 | 2001-02-28 | 鲍德杰克特疫苗公司 | 透皮给药微粒疫苗组合物 |
| EP1048736A1 (en) * | 1999-04-27 | 2000-11-02 | Aventis Behring Gesellschaft mit beschränkter Haftung | DNA-construct for the tissue specific expression of a blood coagulation factor |
| CA2450125A1 (en) * | 2001-06-15 | 2002-12-27 | Andre C. Schuh | Gene therapy for hemophilia a |
| ATE527347T1 (de) * | 2001-08-02 | 2011-10-15 | Inst Clayton De La Rech | Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen |
| KR20050048539A (ko) | 2001-10-06 | 2005-05-24 | 메리얼엘엘씨 | ＣｐＧ 제제 및 관련된 방법 |
| WO2005017160A2 (en) | 2003-08-13 | 2005-02-24 | Children's Hospital Medical Center | Mobilization of hematopoietic cells |
| JP2008518610A (ja) * | 2004-11-03 | 2008-06-05 | アルマック ダイアグノスティックス リミテッド | トランスクリプトームマイクロアレイ技法およびそれを使用する方法 |
| KR100981092B1 (ko) * | 2008-02-29 | 2010-09-08 | 고려대학교 산학협력단 | 제8 혈액응고 인자와 폰 빌리 블란트 인자 변이체의 재조합발현 벡터 시스템 |
| WO2010075303A1 (en) * | 2008-12-23 | 2010-07-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same |
| US8147820B2 (en) | 2009-09-14 | 2012-04-03 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Attenuated vaccine against fish pathogen Francisella sp |
| RU2579977C2 (ru) * | 2009-11-13 | 2016-04-10 | Грифольс Терапьютикс Инк. | СОДЕРЖАЩИЕ ФАКТОР ФОН ВИЛЛЕБРАНДА (vWF) ПРЕПАРАТЫ И СПОСОБЫ, НАБОРЫ И ПРИМЕНЕНИЯ, СВЯЗАННЫЕ С НИМИ |
| US20120225028A1 (en) | 2011-03-02 | 2012-09-06 | Moshe Cohen | Compositions and methods for mobilization of stem cells |
-
2013
- 2013-10-24 BR BR112015009229-2A patent/BR112015009229B1/pt active IP Right Grant
- 2013-10-24 JP JP2015539804A patent/JP2016501515A/ja active Pending
- 2013-10-24 ES ES13848463T patent/ES2854754T3/es active Active
- 2013-10-24 CA CA2888982A patent/CA2888982C/en active Active
- 2013-10-24 EP EP21150184.6A patent/EP3859004A1/en active Pending
- 2013-10-24 PL PL13848463T patent/PL2912186T3/pl unknown
- 2013-10-24 KR KR1020157012821A patent/KR101819803B1/ko active Active
- 2013-10-24 DK DK13848463.9T patent/DK2912186T3/da active
- 2013-10-24 US US14/437,457 patent/US9982034B2/en active Active
- 2013-10-24 EP EP13848463.9A patent/EP2912186B1/en active Active
- 2013-10-24 WO PCT/US2013/066651 patent/WO2014066663A1/en not_active Ceased
-
2015
- 2015-04-21 IL IL238417A patent/IL238417B/en active IP Right Grant
- 2015-04-29 ZA ZA2015/02945A patent/ZA201502945B/en unknown
-
2017
- 2017-08-29 US US15/689,875 patent/US10294291B2/en active Active
-
2018
- 2018-07-19 JP JP2018135886A patent/JP6975105B2/ja active Active
-
2019
- 2019-03-22 US US16/361,591 patent/US20190270791A1/en not_active Abandoned
-
2023
- 2023-08-07 US US18/366,237 patent/US20240270822A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bi et al. | Fusogenic micropeptide Myomixer is essential for satellite cell fusion and muscle regeneration | |
| Abba et al. | MicroRNA regulation of epithelial to mesenchymal transition | |
| SA520411173B1 (ar) | Pd-l1 عوامل ربط ترتبط بـ واستخدامها cd137 | |
| JP2016500260A5 (enExample) | ||
| Roato et al. | Cancer stem cells, bone and tumor microenvironment: key players in bone metastases | |
| RU2021132734A (ru) | Химерные рецепторы антигена, нацеленные на psca | |
| JP2018522072A5 (enExample) | ||
| MX2020005282A (es) | Vector para la produccion de particulas aav. | |
| JP2015525065A5 (enExample) | ||
| HRP20210057T1 (hr) | Presađivanje stem stanica s kombinacijom sredstva koje cilja stem stanice i modulacija imunoregulatorne signalizacije | |
| BR112013007862A2 (pt) | ácidos nucleicos manipulados e métodos de uso dos mesmos. | |
| JP2019508051A5 (enExample) | ||
| RU2020103811A (ru) | Гуманизированные животные по с5 и с3 | |
| EA201401319A1 (ru) | Способы и композиции рнк-специфической модификации днк-мишении рнк-специфической модуляции транскрипции | |
| EA201590488A1 (ru) | Способы модификации клеток-хозяев | |
| JP2016518142A5 (enExample) | ||
| JP2012065652A5 (enExample) | ||
| EA201690355A1 (ru) | Инсектицидные полипептиды с широким спектром активности и их применения | |
| JP2017536826A5 (enExample) | ||
| O’Connor | Molecular profiles of cell‐to‐cell variation in the regenerative potential of mesenchymal stromal cells | |
| UA115235C2 (uk) | Ген токсину axmi335 bacillus thuringiensis та спосіб його застосування | |
| IL269187B1 (en) | Dominant active yap, a hippo effector, induces chromatin accessiblity and cardiomyocyte renewal | |
| AR125194A2 (es) | Una planta transgénica que presenta un rendimiento mejorado y tolerancia al estrés abiótico, y método de obtención de dicha planta | |
| Yi et al. | Stem-like T cells and niches: Implications in human health and disease | |
| Egea-Zorrilla et al. | Promises and challenges of cell-based therapies to promote lung regeneration in idiopathic pulmonary fibrosis |